This month, in Allergan USA, Inc. v. MSN Laboratories Private Ltd., the Federal Circuit added to the ongoing patent-family drama...

Copyright attorneys eagerly anticipated the U.S. Supreme Court's fair use opinion in Andy Warhol Foundation for the Visual Arts, Inc. v....

The district court in Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc., Civil Action No. 20-430-RGA (D. Del.) was asked...

Because judicial resources are limited, virtually all courts impose length limitations, such as word, page, or line limits, for briefing....

Although unusual, we have all heard of an attorney being disqualified from representing a client. We are also familiar with that...

Manufacturers of pharmaceuticals, biologics, and herbicides, as well as companies in virtually every industry, routinely make statements...

Based on recent headlines involving the expansion of the National Women's Soccer League, including its new $240 million media deals, the...

As we all know, injunctions are virtually impossible to obtain in federal patent litigation. However, the U.S. International Trade...

On October 17, 2023, the SEC issued a press release relating to certain defendants in a case brought against RenovaCare, Inc. and certain...

It was interesting to recently hear that Microsoft will pay legal damages on behalf of customers using its artificial intelligence (AI)...

The New York Times recently reported that the Federal Trade Commission (FTC) has opened an investigation into OpenAI, the startup behind...

In a stunning turn of events, a federal judge ruled that the Ripple Labs token (XRP) is deemed a security when sold to sophisticated...